• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Discovery and Development of Cyclic Peptide Inhibitors of CIB1.CIB1环肽抑制剂的发现与开发
ACS Med Chem Lett. 2021 Oct 27;12(11):1832-1839. doi: 10.1021/acsmedchemlett.1c00438. eCollection 2021 Nov 11.
2
Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1.钙和整合素结合蛋白 1 的肽抑制剂的发现和特性。
ACS Chem Biol. 2020 Jun 19;15(6):1505-1516. doi: 10.1021/acschembio.0c00144. Epub 2020 May 26.
3
Mutagenesis and Modeling of Decoy Peptides Targeting CIB1 to Obscure its Role in Triple-negative Breast Cancer Progression.靶向CIB1的诱饵肽的诱变与建模以掩盖其在三阴性乳腺癌进展中的作用
Curr Pharm Des. 2023;29(8):630-638. doi: 10.2174/1381612829666230327162852.
4
CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer.CIB1缺失会损害三阴性乳腺癌中的细胞存活和肿瘤生长。
Breast Cancer Res Treat. 2015 Jul;152(2):337-46. doi: 10.1007/s10549-015-3458-4. Epub 2015 Jun 24.
5
Research Advances of Calcium-and Integrin-binding Protein 1 in Tumors.钙结合整合素结合蛋白1在肿瘤中的研究进展
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Oct 30;39(5):721-726. doi: 10.3881/j.issn.1000-503X.2017.05.020.
6
Strategies for Targeting CIB1: A Challenging Drug Target.靶向 CIB1:极具挑战性的药物靶点策略。
Curr Pharm Des. 2022;28(28):2343-2348. doi: 10.2174/1381612828666220728101812.
7
CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death.用多西他赛或TRAIL抑制CIB1可增强三阴性乳腺癌细胞的死亡。
Cancer Cell Int. 2019 Feb 4;19:26. doi: 10.1186/s12935-019-0740-2. eCollection 2019.
8
Effects of metal-binding loop mutations on ligand binding to calcium- and integrin-binding protein 1. Evolution of the EF-hand?金属结合环突变对配体与钙和整合素结合蛋白1结合的影响。EF手结构域的进化?
Biochemistry. 2008 Feb 12;47(6):1696-707. doi: 10.1021/bi701494m. Epub 2008 Jan 16.
9
Domain stability and metal-induced folding of calcium- and integrin-binding protein 1.钙和整合素结合蛋白1的结构域稳定性及金属诱导折叠
Biochemistry. 2007 Jun 19;46(24):7088-98. doi: 10.1021/bi700200z. Epub 2007 May 22.
10
Structural and biochemical characterization of CIB1 delineates a new family of EF-hand-containing proteins.CIB1的结构和生化特性揭示了一个新的含EF手型结构域蛋白家族。
J Biol Chem. 2005 Mar 4;280(9):8407-15. doi: 10.1074/jbc.M411515200. Epub 2004 Dec 1.

引用本文的文献

1
Functionally active modulators targeting the LRRK2 WD40 repeat domain identified by FRASE-bot in CACHE Challenge #1.通过FRASE-bot在CACHE挑战#1中鉴定出的靶向LRRK2 WD40重复结构域的功能活性调节剂。
Chem Sci. 2025 Jan 9;16(8):3430-3439. doi: 10.1039/d4sc07532c. eCollection 2025 Feb 19.
2
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.用设计肽模拟物和合成生物制剂攻克不可成药靶点。
Chem Rev. 2024 Nov 27;124(22):13020-13093. doi: 10.1021/acs.chemrev.4c00423. Epub 2024 Nov 14.
3
Small-Molecule Disruptors of the Interaction between Calcium- and Integrin-Binding Protein 1 and Integrin αβ as Novel Antiplatelet Agents.钙结合整合素结合蛋白1与整合素αβ相互作用的小分子干扰剂作为新型抗血小板药物
ACS Pharmacol Transl Sci. 2024 May 29;7(7):1971-1982. doi: 10.1021/acsptsci.4c00026. eCollection 2024 Jul 12.
4
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot.基于 FRASE-bot 的基于片段的计算机虚拟筛选发现 CIB1 定向抗肿瘤剂。
Nat Commun. 2024 Jul 2;15(1):5564. doi: 10.1038/s41467-024-49892-9.
5
Cell-free biosynthesis and engineering of ribosomally synthesized lanthipeptides.无细胞生物合成和核糖体合成的聚酮肽工程。
Nat Commun. 2024 May 21;15(1):4336. doi: 10.1038/s41467-024-48726-y.
6
HighFold: accurately predicting structures of cyclic peptides and complexes with head-to-tail and disulfide bridge constraints.HighFold:准确预测具有头对尾和二硫键约束的环状肽和复合物的结构。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae215.
7
Macrocyclic Peptides Closed by a Thioether-Bipyridyl Unit That Grants Cell Membrane Permeability.由赋予细胞膜通透性的硫醚-联吡啶单元封闭的大环肽。
ACS Bio Med Chem Au. 2023 Aug 13;3(5):429-437. doi: 10.1021/acsbiomedchemau.3c00027. eCollection 2023 Oct 18.
8
Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer.三阴性乳腺癌靶向治疗和免疫调节中肽的现状与展望。
Front Immunol. 2023 Aug 25;14:1255820. doi: 10.3389/fimmu.2023.1255820. eCollection 2023.
9
Identification of Covalent Cyclic Peptide Inhibitors in mRNA Display.基于 mRNA 展示技术的共价环状肽抑制剂的鉴定。
J Am Chem Soc. 2023 Jul 19;145(28):15065-15070. doi: 10.1021/jacs.3c04833. Epub 2023 Jul 3.
10
Tyrosinase-Catalyzed Peptide Macrocyclization for mRNA Display.酪氨酸酶催化的肽大环化用于 mRNA 展示。
J Am Chem Soc. 2023 May 17;145(19):10445-10450. doi: 10.1021/jacs.2c12629. Epub 2023 May 8.

本文引用的文献

1
Discovery and Characterization of Peptide Inhibitors for Calcium and Integrin Binding Protein 1.钙和整合素结合蛋白 1 的肽抑制剂的发现和特性。
ACS Chem Biol. 2020 Jun 19;15(6):1505-1516. doi: 10.1021/acschembio.0c00144. Epub 2020 May 26.
2
Cell Penetration Profiling Using the Chloroalkane Penetration Assay.利用氯烷渗透测定法进行细胞渗透分析。
J Am Chem Soc. 2018 Sep 12;140(36):11360-11369. doi: 10.1021/jacs.8b06144. Epub 2018 Aug 31.
3
Emerging Methods and Design Principles for Cell-Penetrant Peptides.穿细胞肽的新兴方法和设计原则。
Angew Chem Int Ed Engl. 2018 Sep 10;57(37):11868-11881. doi: 10.1002/anie.201801361. Epub 2018 Aug 17.
4
Structural and conformational determinants of macrocycle cell permeability.大环化合物细胞通透性的结构和构象决定因素。
Nat Chem Biol. 2016 Dec;12(12):1065-1074. doi: 10.1038/nchembio.2203. Epub 2016 Oct 17.
5
CIB1: a small protein with big ambitions.CIB1:一个抱负远大的小蛋白。
FASEB J. 2016 Aug;30(8):2640-50. doi: 10.1096/fj.201500073R. Epub 2016 Apr 26.
6
Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides.高效环化细胞穿透肽的发现与作用机制
Biochemistry. 2016 May 10;55(18):2601-12. doi: 10.1021/acs.biochem.6b00226. Epub 2016 Apr 28.
7
Cell permeability beyond the rule of 5.超过 5 规则的细胞通透性。
Adv Drug Deliv Rev. 2016 Jun 1;101:42-61. doi: 10.1016/j.addr.2016.03.013. Epub 2016 Apr 9.
8
Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.小分子,大目标:药物发现面临蛋白-蛋白相互作用挑战。
Nat Rev Drug Discov. 2016 Aug;15(8):533-50. doi: 10.1038/nrd.2016.29. Epub 2016 Apr 11.
9
CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer.CIB1缺失会损害三阴性乳腺癌中的细胞存活和肿瘤生长。
Breast Cancer Res Treat. 2015 Jul;152(2):337-46. doi: 10.1007/s10549-015-3458-4. Epub 2015 Jun 24.
10
Review cyclic peptides on a merry-go-round; towards drug design.在旋转木马上审视环肽;迈向药物设计。
Biopolymers. 2015 Sep;104(5):453-61. doi: 10.1002/bip.22669.

CIB1环肽抑制剂的发现与开发

Discovery and Development of Cyclic Peptide Inhibitors of CIB1.

作者信息

Haberman Victoria A, Fleming Steven R, Leisner Tina M, Puhl Ana C, Feng Emerald, Xie Ling, Chen Xian, Goto Yuki, Suga Hiroaki, Parise Leslie V, Kireev Dmitri, Pearce Kenneth H, Bowers Albert A

机构信息

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

Center for Integrative Chemical Biology and Drug Discovery, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.

出版信息

ACS Med Chem Lett. 2021 Oct 27;12(11):1832-1839. doi: 10.1021/acsmedchemlett.1c00438. eCollection 2021 Nov 11.

DOI:10.1021/acsmedchemlett.1c00438
PMID:34795874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8591747/
Abstract

Calcium and integrin binding protein 1 (CIB1) is a small, intracellular protein recently implicated in survival and proliferation of triple-negative breast cancer (TNBC). Considering its interactions with PAK1 and downstream signaling, CIB1 has been suggested as a potential therapeutic target in TNBC. As such, CIB1 has been the focus of inhibitor discovery efforts. To overcome issues of potency and stability in previously reported CIB1 inhibitors, we deploy mRNA display to discover new cyclic peptide inhibitors with improved biophysical properties and cellular activity. We advance UNC10245131, a cyclic peptide with low nanomolar affinity and good selectivity for CIB1 over other EF-hand domain proteins and improved permeability and stability over previously identified linear peptide inhibitor UNC10245092. Unlike UNC10245092, UNC10245131 lacks cytotoxicity and does not affect downstream signaling. Despite this, UNC10245131 is a potent ligand that could aid in clarifying roles of CIB1 in TNBC survival and proliferation and other CIB1-associated biological phenotypes.

摘要

钙与整合素结合蛋白1(CIB1)是一种小分子细胞内蛋白,最近被认为与三阴性乳腺癌(TNBC)的存活和增殖有关。鉴于其与PAK1及下游信号传导的相互作用,CIB1被认为是TNBC的一个潜在治疗靶点。因此,CIB1一直是抑制剂研发工作的重点。为克服先前报道的CIB1抑制剂在效力和稳定性方面的问题,我们利用mRNA展示技术来发现具有改善的生物物理性质和细胞活性的新型环肽抑制剂。我们推进了UNC10245131的研究,这是一种环肽,对CIB1具有低纳摩尔亲和力,相对于其他EF手型结构域蛋白具有良好的选择性,并且与先前鉴定的线性肽抑制剂UNC10245092相比,其通透性和稳定性有所提高。与UNC10245092不同,UNC10245131没有细胞毒性,也不影响下游信号传导。尽管如此,UNC10245131是一种有效的配体,有助于阐明CIB1在TNBC存活和增殖以及其他与CIB1相关的生物学表型中的作用。